Goldstein says that this stem cell research is bringing scientists closer to being able to test drugs for Alzheimer's - a disease that affects more than five million Americans.
The compound is similar to Medivation Inc and Pfizer Inc's experimental Alzheimer's drug, Dimebon, and may provide ways to improve its effects, Pieper and colleagues reported in the journal Cell.